Patterns of melastatin mRNA expression in melanocytic tumors
- 1 November 2000
- journal article
- Published by Elsevier in Human Pathology
- Vol. 31 (11), 1346-1356
- https://doi.org/10.1016/s0046-8177(00)80003-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190Journal of Clinical Oncology, 2000
- Tumor Progression, Early Diagnosis and Prognosis of MelanomaActa Oncologica, 1999
- Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic LesionsJournal of Investigative Dermatology, 1998
- Neoplastic progression and prognosis in melanomaSeminars in Cutaneous Medicine and Surgery, 1996
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Tumour progression and the nature of cancerBritish Journal of Cancer, 1991
- Prognostic Significance of DNA Aneuploidy in Stage I Cutaneous MelanomaAnnals of Surgery, 1988
- Phenotypic dynamics of tumor progression in human malignant melanomaInternational Journal of Cancer, 1985
- A study of tumor progression: The precursor lesions of superficial spreading and nodular melanomaHuman Pathology, 1984
- Biological Diversity in Metastatic Neoplasms: Origins and ImplicationsScience, 1982